Experimental Drug Development Centre

Publication date Article title Author(s)
26 Dec 2022 Targeting SARS-CoV-2 and host cell receptor interactions Siew Pheng Lim
5 Nov 2022 Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses Zhewei Shen, Anna Halberg, Jia Yi Fong, Jingyu Guo, Gavin Song, Brent Louie, Gregory R. Luedtke, Viwat Visuthikraisee, Andrew A. Protter, Xiaoying Koh, Taegon Baik, Pek Yee Lum
19 Aug 2022 Oral Nonpeptidic, Noncovalent Triazine Coronavirus Main Protease Inhibitors for Treating COVID-19 C. S. Brian Chia, Masafumi Inoue
8 Aug 2022 Novel Coronavirus Main Protease Di- and Tripeptide Inhibitors for Treating COVID-19 C. S. Brian Chia, Yi Yang See
19 Jul 2022 A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir Subramanyam Vankadara, Monique Danielle Dawson, Jia Yi Fong, Qin Yao Oh, Qi An Ang, Boping Liu, Hong Yun Chang, Judice Koh, Xiaoying Koh, Qian Wen Tan, Joma Joy, Cheng San Brian Chia
27 May 2022 Novel Halomethylketone Azadipeptides for Treating COVID-19 C. S. Brian Chia, Yi Yang See
5 Apr 2022 A Patent Review on FDA‐Approved Antibody‐Drug Conjugates, Their Linkers and Drug Payloads C. S. Brian Chia
5 Mar 2022 Application of High Throughput Technologies in the Development of Acute Myeloid Leukemia Therapy: Challenges and Progress Wei Xiang, Yi Hui Lam, Giridharan Periyasamy, Charles Chuah
18 Feb 2022 Structures and Dynamics of Dengue Virus Nonstructural Membrane Proteins Qingxin Li, CongBao Kang
3 Feb 2022 Novel Nitrile Peptidomimetics for Treating COVID-19 C. S. Brian Chia